Blood-Brain Barrier Dysfunction in Vascular Cognitive Impairment
📖 Wiki Page
mechanism1325 wordssynced 2026-04-02
Blood-Brain Barrier Dysfunction in Vascular Cognitive Impairment
Introduction
Blood-brain barrier (BBB) dysfunction is a central pathogenic mechanism linking cerebrovascular disease to cognitive decline in [Vascular Cognitive Impairment (VCI)](/diseases/vascular-dementia) and [Vascular Dementia (VaD)](/diseases/vascular-dementia). Unlike Alzheimer's disease where BBB breakdown is primarily driven by amyloid-beta pathology, VCI-associated BBB dysfunction arises from chronic hypertension, diabetes, small vessel disease, and aging — converging on endothelial injury, pericyte degeneration, and neurovascular uncoupling [@iadecola2013].
The BBB deterioration in VCI follows a characteristic sequence: risk factors (hypertension, diabetes, aging) first impair endothelial function, then disrupt pericyte coverage and tight junction integrity, leading to perivascular leakage of blood-derived proteins, reduced clearance of neurotoxins, and ultimately neuronal dysfunction and cognitive decline [@sweeney2019].
Structural Components of the BBB in VCI
Endothelial Cells
Brain endothelial cells in VCI undergo significant structural and functional changes:
...
Blood-Brain Barrier Dysfunction in Vascular Cognitive Impairment
Introduction
Blood-brain barrier (BBB) dysfunction is a central pathogenic mechanism linking cerebrovascular disease to cognitive decline in [Vascular Cognitive Impairment (VCI)](/diseases/vascular-dementia) and [Vascular Dementia (VaD)](/diseases/vascular-dementia). Unlike Alzheimer's disease where BBB breakdown is primarily driven by amyloid-beta pathology, VCI-associated BBB dysfunction arises from chronic hypertension, diabetes, small vessel disease, and aging — converging on endothelial injury, pericyte degeneration, and neurovascular uncoupling [@iadecola2013].
The BBB deterioration in VCI follows a characteristic sequence: risk factors (hypertension, diabetes, aging) first impair endothelial function, then disrupt pericyte coverage and tight junction integrity, leading to perivascular leakage of blood-derived proteins, reduced clearance of neurotoxins, and ultimately neuronal dysfunction and cognitive decline [@sweeney2019].
Structural Components of the BBB in VCI
Endothelial Cells
Brain endothelial cells in VCI undergo significant structural and functional changes:
Tight junction disruption: Claudin-5, occludin, and ZO-1 proteins become mislocalized and downregulated, increasing paracellular permeability [@sweeney2019]
Reduced LRP1 expression: Decreases amyloid-beta efflux from brain to blood, contributing to accumulation [@deane2012]
Endothelial adhesion molecule upregulation: ICAM-1, VCAM-1, and P-selectin facilitate leukocyte extravasation and neuroinflammation [@blann2005]
Small Vessel Disease and BBB
Cerebral small vessel disease (CSVD) and BBB dysfunction form a vicious cycle in VCI:
Lipohyalinosis: Fibrinoid necrosis of small vessel walls disrupts the neurovascular unit
Lacunar infarcts: Perivascular leakage precedes and predicts lacunar stroke formation
White matter lesions: BBB breakdown allows fibrinogen, albumin, and immunoglobulin extravasation into white matter, triggering demyelination and axonal injury [@montagner2015]
Periventricular predominance: The periventricular white matter is most vulnerable due to lower pericyte coverage
Glymphatic System Impairment
The glymphatic system — the brain's perivascular waste clearance pathway — is compromised in VCI:
AQP4 mislocalization from astrocyte end-feet reduces convective flow through the interstitial space
Perivascular fibrinogen and albumin deposits obstruct glymphatic flow channels
Reduced glymphatic clearance contributes to accumulation of neurotoxic proteins
Sleep disruption (common in VCI patients) further reduces glymphatic function
BBB Transporters in VCI
LRP1 (Low-Density Lipoprotein Receptor-Related Protein 1)
Mediates efflux of amyloid-beta from brain to blood
Expression is reduced in VCI, contributing to amyloid accumulation and [cerebral amyloid angiopathy (CAA)](/mechanisms/cerebral-amyloid-angiopathy)
APOE2/3 bind LRP1 with higher affinity than APOE4, explaining higher VCI risk in APOE4 carriers
Enhancing LRP1 function is a therapeutic strategy for VCI [@deane2012]
RAGE (Receptor for Advanced Glycation End Products)
Mediates blood-to-brain influx of amyloid-beta and inflammatory mediators
Upregulated in VCI endothelial cells by chronic hyperglycemia and oxidative stress